81 related articles for article (PubMed ID: 7585657)
1. Angiofollicular lymph node hyperplasia (Castleman's disease).
McCarty MJ; Vukelja SJ; Banks PM; Weiss RB
Cancer Treat Rev; 1995 Jul; 21(4):291-310. PubMed ID: 7585657
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes in patients with human immunodeficiency virus-negative, Castleman's disease: a single medical center study in Tunisia.
Chabchoub I; Salah RB; Kallel R; Snoussi M; Frikha F; Marzouk S; Boudawara TS; Bahloul Z
Rom J Intern Med; 2024 Mar; 62(1):20-32. PubMed ID: 37948573
[TBL] [Abstract][Full Text] [Related]
3. [Castleman's disease in the rheumatological practice].
Schmalzing M; Sander O; Seidl M; Marks R; Blank N; Kötter I; Tiemann M; Backhaus M; Manger B; Hübel K; Müller-Ladner U; Henes J
Z Rheumatol; 2024 May; 83(4):316-326. PubMed ID: 37624374
[TBL] [Abstract][Full Text] [Related]
4. Unicentric Castleman's disease in the parotid gland associated with psoriasis: a case report.
Zhang Y; Li CY; Li Z; Chen W
J Med Case Rep; 2024 Apr; 18(1):140. PubMed ID: 38566262
[TBL] [Abstract][Full Text] [Related]
5. Castleman disease of the parapharyngeal space: Diagnosis and management.
Jbali S; Zarraa S; Hadhri A; Noubbigh GEF; Yahyaoui S; Nasr C
Int J Surg Case Rep; 2022 Oct; 99():107599. PubMed ID: 36113371
[TBL] [Abstract][Full Text] [Related]
6. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
van Rhee F; Oksenhendler E; Srkalovic G; Voorhees P; Lim M; Dispenzieri A; Ide M; Parente S; Schey S; Streetly M; Wong R; Wu D; Maillard I; Brandstadter J; Munshi N; Bowne W; Elenitoba-Johnson KS; Fössa A; Lechowicz MJ; Chandrakasan S; Pierson SK; Greenway A; Nasta S; Yoshizaki K; Kurzrock R; Uldrick TS; Casper C; Chadburn A; Fajgenbaum DC
Blood Adv; 2020 Dec; 4(23):6039-6050. PubMed ID: 33284946
[TBL] [Abstract][Full Text] [Related]
7. Castleman Disease.
Kaur H; Xiang Z; Kunthur A; Mehta P
Fed Pract; 2015 Aug; 32(Suppl 7):41S-46S. PubMed ID: 30766129
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic treatment of abdominal unicentric castleman's disease: a case report and literature review.
Bracale U; Pacelli F; Milone M; Bracale UM; Sodo M; Merola G; Troiani T; Di Salvo E
BMC Surg; 2017 Apr; 17(1):38. PubMed ID: 28403848
[TBL] [Abstract][Full Text] [Related]
9. A Palpable Painless Axillary Mass as the Clinical Manifestation of Castleman's Disease in a Patient with Hepatitis C Disease.
Papazafiropoulou AK; Angelidi AM; Kousoulis AA; Christofilidis G; Sagia C; Kaftanidou L; Manoloudaki K; Tsavari A; Kranidiotis G; Kamaratos A; Melidonis A
Case Rep Med; 2016; 2016():1970276. PubMed ID: 27313621
[TBL] [Abstract][Full Text] [Related]
10. Castleman's Disease Presenting as Peri - Pancreatic Neoplasm.
Shetty PS; Patkar S; Shet T; Goel M; Shrikhande SV
Indian J Surg Oncol; 2015 Mar; 6(1):26-9. PubMed ID: 25937760
[TBL] [Abstract][Full Text] [Related]
11. Castleman's Disease, a Case report.
Reddy R; Singhania A; George A; Kumar R; Kumar S
Iran J Otorhinolaryngol; 2011; 23(65):157-60. PubMed ID: 24303376
[TBL] [Abstract][Full Text] [Related]
12. Localized Castleman's disease in the breast.
Vieira RA; Kunizaki JS; do Canto AL; Mendes AD; Vial JS; Matthes AG; Watanabe AU; Scapulatempo Neto C
Int J Surg Case Rep; 2013; 4(3):325-9. PubMed ID: 23416500
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and outcome of patients with HIV-negative multicentric Castleman's disease treated with combination chemotherapy: a report on 10 patients.
Zhu SH; Yu YH; Zhang Y; Sun JJ; Han DL; Li J
Med Oncol; 2013 Mar; 30(1):492. PubMed ID: 23400962
[TBL] [Abstract][Full Text] [Related]
14. Unicentric Castleman's Disease Masquerading Pancreatic Neoplasm.
Jain S; Chatterjee S; Swain JR; Rakshit P; Chakraborty P; Sinha S
Case Rep Oncol Med; 2012; 2012():793403. PubMed ID: 23227386
[TBL] [Abstract][Full Text] [Related]
15. Extrathoracic castleman'S disease - presenting as a neck mass.
Shukla A; Bhaduri A; Pachauri R
Indian J Otolaryngol Head Neck Surg; 2000 Jul; 52(3):266-8. PubMed ID: 23119691
[TBL] [Abstract][Full Text] [Related]
16. Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature.
Matthiesen C; Ramgopol R; Seavey J; Ahmad S; Herman T
Radiol Oncol; 2012 Sep; 46(3):265-70. PubMed ID: 23077466
[TBL] [Abstract][Full Text] [Related]
17. Plasma cell type of Castleman's disease involving renal parenchyma and sinus with cardiac tamponade: case report and literature review.
Kim TU; Kim S; Lee JW; Lee NK; Jeon UB; Ha HG; Shin DH
Korean J Radiol; 2012; 13(5):658-63. PubMed ID: 22977337
[TBL] [Abstract][Full Text] [Related]
18. The clinical spectrum of Castleman's disease.
Dispenzieri A; Armitage JO; Loe MJ; Geyer SM; Allred J; Camoriano JK; Menke DM; Weisenburger DD; Ristow K; Dogan A; Habermann TM
Am J Hematol; 2012 Nov; 87(11):997-1002. PubMed ID: 22791417
[TBL] [Abstract][Full Text] [Related]
19. A case of cervical multicentric Castleman disease treated with intensity-modulated radiation therapy using helical tomotherapy.
Tomita N; Kodaira T; Tomoda T; Nakajima K; Murao T; Kitamura K
Jpn J Radiol; 2012 May; 30(4):349-53. PubMed ID: 22258813
[TBL] [Abstract][Full Text] [Related]
20. Castleman's Disease with Cutaneous Involvement Manifestating as Multiple Violaceous Plaques on Entire Body.
Park HY; Lee JJ; Lee JB; Kim SJ; Lee SC; Won YH; Yun SJ
Ann Dermatol; 2011 Oct; 23(Suppl 2):S169-74. PubMed ID: 22148042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
